E10.3413 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral

Name of the Condition

• Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral

Summary

Type 1 diabetes mellitus is a chronic autoimmune condition characterized by insufficient insulin production. When associated with severe nonproliferative diabetic retinopathy with macular edema, it indicates advanced retinal damage due to prolonged hyperglycemia. This stage involves widespread microaneurysms, intraretinal hemorrhages, venous beading, and intraretinal microvascular abnormalities without neovascularization, along with fluid accumulation in the macula. Close monitoring is essential to prevent progression to proliferative disease or vision loss.

Causes

Type 1 diabetes arises from an autoimmune response that destroys insulin-producing beta cells in the pancreas. Severe nonproliferative diabetic retinopathy with macular edema develops as a result of sustained high blood glucose levels, which damage retinal blood vessels over time. The exact mechanisms involve oxidative stress, inflammation, and vascular changes specific to ocular structures, leading to progressive retinal ischemia and macular fluid leakage.

Risk Factors

• Poor glycemic control
• Duration of diabetes (longer exposure increases risk)
• Hypertension
• Dyslipidemia
• Smoking
• Genetic predisposition to diabetic eye disease

Symptoms

• Blurred or distorted central vision
• Difficulty reading or recognizing faces
• Central visual field defects
• Fluctuating vision
• Reduced color perception

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, slit-lamp biomicroscopy, and optical coherence tomography (OCT) to assess macular edema. Fundus photography and fluorescein angiography may be used to evaluate retinal microvascular abnormalities. Blood glucose and HbA1c levels are measured to confirm diabetes control. Bilateral involvement is confirmed by examining both eyes.

Treatment Options

• Intravitreal anti-VEGF injections to reduce macular edema and improve vision
• Focal or grid laser photocoagulation to treat macular edema
• Intensive glycemic control to slow disease progression
• Blood pressure and lipid management
• Regular follow-up with an ophthalmologist

Prognosis and Follow-Up

Prognosis depends on early detection and treatment. With proper management, vision loss can be minimized, but some patients may experience permanent vision impairment. Follow-up typically includes regular eye exams every 3–6 months, with more frequent visits if edema or retinopathy progresses. Long-term monitoring is essential to detect proliferative changes.

Complications

• Progression to proliferative diabetic retinopathy
• Permanent vision loss or blindness
• Cataracts
• Glaucoma
• Increased risk of cardiovascular events due to diabetes

Lifestyle & Prevention

• Maintain strict glycemic control through insulin therapy and monitoring
• Regular physical activity and a balanced diet
• Blood pressure and cholesterol management
• Avoid smoking
• Routine eye screenings to detect early retinal changes

When to Seek Professional Help

Seek immediate care if you experience sudden vision loss, floaters, or flashes, as these may indicate retinal detachment or hemorrhage. Regular ophthalmologic evaluations are critical for early intervention.

Tips for Medical Coders

Document the bilateral nature of the condition clearly in the medical record. Ensure the diagnosis includes both eyes and specifies severe nonproliferative diabetic retinopathy with macular edema. Verify that the code aligns with clinical findings and documentation of bilateral involvement.